Effects of cannabidiol on the function of α7-nicotinic acetylcholine receptors

European Journal of Pharmacology

Volumn 720, Issue 1-3, 2013, Pages 310-319

  Mahgoub, Mohamed ^a   Keun Hang, Susan Yang ^b   Sydorenko, Vadym ^a,c   Ashoor, Abrar ^a   Kabbani, Nadine ^d   Al Kury, Lina ^a   Sadek, Bassem ^a   Howarth, Christopher F ^a   Isaev, Dmytro ^a,c   Galadari, Sehamuddin ^a   Oz, Murat ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b Chapman Schmid College of Science   (United States)

^c BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

^d GEORGE MASON UNIVERSITY   (United States)

Author keywords

Cannabidiol; Cannabinoids; Nicotinic receptors; Xenopus oocyte

Indexed keywords

ACETYLCHOLINE; BARIUM ION; BUNGAROTOXIN RECEPTOR; CALCIUM ACTIVATED CHLORIDE CHANNEL; CANNABIDIOL; CANNABINOL; COMPLEMENTARY RNA; DRONABINOL; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); IODINE 125; NICOTINE; NICOTINIC RECEPTOR; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BRAIN SLICE; CONCENTRATION RESPONSE; FEMALE; HIPPOCAMPAL CA1 REGION; INTERNEURON; ISOTOPE LABELING; MEMBRANE BINDING; MEMBRANE POTENTIAL; NONHUMAN; NORADRENALIN RELEASE; OOCYTE; PRIORITY JOURNAL; PROTEIN FUNCTION; STRATUM RADIATUM; VOLTAGE CLAMP TECHNIQUE; WHOLE CELL PATCH CLAMP; XENOPUS LAEVIS;

1,2-BIS (O-AMINOPHENOXY) ETHANE-N, N,N′,N′-TETRAACETIC ACID; 4-(2-HYDROXYETHYL) PIPERAZINEETHANE SULFONIC ACID; ACETYLCHOLINE; ACH; ANALYSIS OF VARIANCE; ANOVA; BAPTA; CANNABIDIOL; CANNABINOIDS; DIMETHYL SULFOXIDE; DMSO; HEPES; MBS; MODIFIED BARTH'S SOLUTION; NICOTINIC RECEPTORS; PERTUSSIS TOXIN.; PTX; XENOPUS OOCYTE;

ACETYLCHOLINE; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; BUNGAROTOXINS; CANNABIDIOL; CHOLINE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HIPPOCAMPUS; HUMANS; MALE; NICOTINE; NICOTINIC ANTAGONISTS; NOREPINEPHRINE; OOCYTES; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; XENOPUS LAEVIS;

EID: 84890129248     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.10.011     Document Type: Article

References (50)

1. J. Ahrens, R. Demir, M. Leuwer, J. de la Roche, K. Krampfl, N. Foadi, M. Karst, and G. Haeseler The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-beta glycine receptor function Pharmacology 83 2009 217 222
2. Ashoor, A., Lorke, D., Nurulain, S.M., Kury, L.A., Petroianu, G., Yang, K.H., and Oz, M., 2011. Effects of phenothiazine-class antipsychotics on the function of α7-nicotinic acetylcholine receptors. Eur. J. Pharmacol. 673, 25-32.
3. E.X. Albuquerque, E.F. Pereira, M. Alkondon, and S.W. Rogers Mammalian nicotinic acetylcholine receptors: from structure to function Physiol. Rev. 2009 73 120 (in United States)
4. U. Baranowska, M. Gothert, R. Rudz, and B. Malinowska Methanandamide allosterically inhibits in vivo the function of peripheral nicotinic acetylcholine receptors containing the alpha 7-subunit J. Pharmacol. Exp. Ther. 2008 912 919 (in United States)
5. T. Bisogno, L. Hanus, L. De Petrocellis, S. Tchilibon, D.E. Ponde, I. Brandi, A.S. Moriello, J.B. Davis, R. Mechoulam, and V. Di Marzo Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide Br. J. Pharmacol. 134 2001 845 852 (Pubitemid 33016156)
6. N.L. Cluny, R.J. Naylor, B.A. Whittle, and F.A. Javid The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus Arch. Pharm. Res. 34 2011 1509 1517
7. L. De Petrocellis, V. Vellani, A. Schiano-Moriello, P. Marini, P.C. Magherini, P. Orlando, and V. Di Marzo Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8 J. Pharmacol. Exp. Ther. 325 2008 1007 1015 (Pubitemid 351724325)
8. 2+ elevations in hippocampal cells Neuropharmacology 50 2006 621 631
9. C.P. Fenster, T.L. Whitworth, E.B. Sheffield, M.W. Quick, and R.A. Lester Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine J. Neurosci. 19 1999 4804 4814 (Pubitemid 29270117)
10. C. Hartzell, I. Putzier, and J. Arreola Calcium-activated chloride channels Annu. Rev. Physiol. 67 2005 719 758 (Pubitemid 40404508)
11. N. Hejazi, C. Zhou, M. Oz, H. Sun, J.H. Ye, and L. Zhang Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors Mol. Pharmacol. 2006 991 997 (in United States) (Pubitemid 43363874)
12. B. Hille Ion Channels of Excitable Membranes 2001-2007 Sinauer Associates Inc
13. A.J. Hill, C.M. Williams, B.J. Whalley, and G.J. Stephens Phytocannabinoids as novel therapeutic agents in CNS disorders Pharmacol. Ther. 133 2012 79 97
14. R.C. Hogg, M. Raggenbass, and D. Bertrand Nicotinic acetylcholine receptors: from structure to brain function Rev. Physiol. Biochem. Pharmacol. 147 2003 1 46
15. D. Isaev, E. Isaeva, T. Shatskih, Q. Zhao, N.C. Smits, N.W. Shworak, R. Khazipov, and G.L. Holmes Role of extracellular sialic acid in regulation of neuronal and network excitability in the rat hippocampus J. Neurosci. 27 2007 11587 11594 (Pubitemid 350006891)
16. Izzo, A.A., Borrelli, F., Capasso, R., Di Marzo, V., Mechoulam, R., 2009. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 30, 515-27.
17. M. Kathmann, K. Flau, A. Redmer, C. Trankle, and E. Schlicker Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors Naunyn Schmiedebergs Arch. Pharmacol. 372 2006 354 361
18. D. Lipinsky, and Y. Oron Alkaline pH facilitates the exchange of guanine nucleotides: a possible mechanism for modulation of the kinetics of responses mediated by guanine nucleotide-binding proteins J. Cell. Physiol. 1996 167 174 (in United States) (Pubitemid 26342526)
19. M. Lodzki, B. Godin, L. Rakou, R. Mechoulam, R. Gallily, and E. Touitou Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model J. Control. Release 93 2003 377 387 (Pubitemid 37485959)
20. S. Mato, M. Victoria Sanchez-Gomez, and C. Matute Cannabidiol induces intracellular calcium elevation and cytotoxicity Glia 58 2010 1739 1747
21. R. Mechoulam, and L. Hanus Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects Chem. Phys. Lipids 121 2002 35 43 (Pubitemid 36044540)
22. R. Mechoulam, M. Peters, E. Murillo-Rodrigiiez, and L.O. Hanus Cannabidiol - recent advances Chem. Biodivers. 4 2007 1678 1692 (Pubitemid 47377200)
23. 7 nicotinic receptor-G protein pathway complex regulates neurite growth in neural cells J. Cell Sci. 125 2012 5502 5513
24. H.O. Onaran, and T. Costa Allosteric coupling and conformational fluctuations in proteins Curr. Protein Pept. Sci. 10 2009 110 115
25. M. Oz Receptor-independent actions of cannabinoids on cell membranes: focus on endocannabinoids Pharmacol. Ther. 111 2006 114 144 (Pubitemid 43786201)
26. 2+ sensors Mol. Pharmacol. 54 1998 1106 1112 (Pubitemid 29002055)
27. M. Oz, A. Ravindran, O. Diaz-Ruiz, L. Zhang, and M. Morales The endogenous cannabinoid anandamide inhibits alpha7 nicotinic acetylcholine J. Pharmacol. Exp. Ther. 306 2003 1003 1010
28. M. Oz, C.E. Spivak, and C.R. Lupica The solubilizing detergents, Tween 80 and Triton X-100 non-competitively inhibit alpha 7-nicotinic acetylcholine receptor function in Xenopus oocytes J. Neurosci. Methods 137 2004 167 173 (Pubitemid 38942877)
29. M. Oz, K.H. Yang, M. Dinc, and T.S. Shippenberg The endogenous cannabinoid anandamide inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes J. Pharmacol. Exp. Ther. 332 2007 547 554 (Pubitemid 350005116)
30. M. Oz, I. Zakharova, M. Dinc, and T. Shippenberg Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes Naunyn Schmiedebergs Arch. Pharmacol. 369 2004 252 259 (Pubitemid 38270784)
31. M. Oz, L. Zhang, A. Ravindran, M. Morales, and C.R. Lupica Differential effects of endogenous and synthetic cannabinoids on alpha7-nicotinic J. Pharmacol. Exp. Ther. 310 2004 1152 1160
32. R.G. Pertwee The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids Br. J. Pharmacol. 153 2008 199 215
33. R.G. Pertwee Emerging strategies for exploiting cannabinoid receptor agonists as medicines Br. J. Pharmacol. 2009 397 411 (in England)
34. R.G. Pertwee Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists Curr. Med. Chem. 17 2010 1360 1381
35. N. Qin, M.P. Neeper, Y. Liu, T.L. Hutchinson, M.L. Lubin, and C.M. Flores TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons J. Neurosci. 28 2008 6231 6238
36. G.K. Rao, and N.E. Kaminski Cannabinoid-mediated elevation of intracellular calcium: a structure-activity J. Pharmacol. Exp. Ther. 317 2006 820 829
37. H.R. Ross, I. Napier, and M. Connor Inhibition of recombinant human T-type calcium channels by Delta(9)-Tetrahydrocannabinol and cannabidiol J. Biol. Chem. 283 2008 16124 16134
38. E.B. Russo, A. Burnett, B. Hall, and K.K. Parker Agonistic properties of cannabidiol at 5-HT1a receptors Neurochem. Res. 30 2005 1037 1043 (Pubitemid 41570039)
39. D. Ryan, A.J. Drysdale, R.G. Pertwee, and B. Platt Differential effects of cannabis extracts and pure plant cannabinoids on Neurosci. Lett. 408 2006 236 241 (Pubitemid 44528872)
40. S.B. Sands, A.C. Costa, and J.W. Patrick Barium permeability of neuronal nicotinic receptor alpha 7 expressed in Xenopus oocytes Biophys. J. 65 1993 2614 2621 (Pubitemid 24005993)
41. C. Scuderi, D. De Filippis, T. Iuvone, A. Blasio, A. Steardo, and G. Esposito Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders Phytother. Res. 23 2009 597 602
42. H. Sharir, and M.E. Abood Pharmacological characterization of GPR55, a putative cannabinoid receptor Pharmacol. Ther. 126 2010 301 313
43. S.K. Singhal, L. Zhang, M. Morales, and M. Oz Antipsychotic clozapine inhibits the function of alpha7-nicotinic acetylcholine receptors Neuropharmacology 52 2007 387 394 (Pubitemid 46137973)
44. A.M. Smith, G.K. Dhawan, Z. Zhang, K.B. Siripurapu, P.A. Crooks, and L.P. Dwoskin The novel nicotinic receptor antagonist, N,N′-dodecane-1,12-diyl- bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices Biochem. Pharmacol. 78 2009 889 897
45. C.E. Spivak, C.R. Lupica, and M. Oz The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors Mol. Pharmacol. 2007 1024 1032 (in United States) (Pubitemid 47481425)
46. V.V. Uteshev alpha7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum Adv. Exp. Med. Biol. 740 2012 603 638
47. S.A. Varvel, J.L. Wiley, R. Yang, D.T. Bridgen, K. Long, A.H. Lichtman, and B.R. Martin Interactions between THC and cannabidiol in mouse models of cannabinoid activity Psychopharmacology (Berl) 186 2006 226 234 (Pubitemid 43727340)
48. W. Xiong, B.N. Koo, R. Morton, and L. Zhang Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanisms Neuroscience 184 2011 28 37
49. K.H. Yang, S. Galadari, D. Isaev, G. Petroianu, T.S. Shippenberg, and M. Oz The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine(3A) receptor-mediated currents in Xenopus laevis oocytes J. Pharmacol. Exp. Ther. 333 2010 547 554 (Pubitemid 350005116)
50. L. Zhang, M. Oz, R.R. Stewart, R.W. Peoples, and F.F. Weight Volatile general anaesthetic actions on recombinant nACh alpha 7, 5-HT3 and chimeric nACh alpha 7-5-HT3 receptors expressed in Xenopus oocytes Br. J. Pharmacol. 120 1997 353 355 (Pubitemid 27052831)